semaglutide portland Weight Loss | GLP-1 Weight Loss | Hormone Therapy | Low-T Semaglutide in South Portland, ME
Description
In a landmark Phase 2 obesity trial, participants receiving the highest dose achieved: Up to ~24% average weight loss at 48 weeks Weight loss had not yet plateaued at the end of the study Potential for even greater reductions with longer treatment duration For context: Semaglutide (GLP-1): ~15% weight loss Tirzepatide (GIP + GLP-1): ~2123% weight loss Retatrutide (GIP + GLP-1 + Glucagon): ~24%+ weight loss in Phase 2 studies Common side effects were similar to other GLP-1based therapies and included nausea, vomiting, diarrhea, constipation, and abdominal discomfort, primarily during dose escalation
Many Canadian imaging centers offer DXA scans for approximately $75-150 CAD, making quarterly testing financially accessible for serious users
doi: 10.1001/jamainternmed.2024.5768
Aoe S, Mio K, Yamanaka C, Kuge T
Get started today What are the side effects of GLP-1 medications
23-25 To resolve this confusion, the prospective FOCUS trial was initiated in 2019
